The incidence of ST segment elevation myocardial infarction (STEMI) has decreased over
the last two decades in developed countries, but mortality from STEMI despite widespread …

Acute myocardial infarction (MI) is a major cause of death and disability worldwide. In
patients with MI, the treatment of choice for reducing acute myocardial ischemic injury and …

The success of a primary percutaneous intervention (PCI) in the setting of ST elevation
myocardial infarction depends on the functional and structural integrity of coronary …

Coronary heart disease (CHD) is the leading cause of death and disability worldwide.
Despite current therapy, the morbidity and mortality for patients with CHD remains …

Cardiovascular diseases, the number 1 cause of death worldwide, are frequently associated
with apoptotic death of cardiac myocytes. Since cardiomyocyte apoptosis is a highly …

Anemia and iron deficiency are common in patients with heart failure (HF), and are
associated with worse symptoms and adverse outcomes in this population. Although the two …

Novel approaches are required to improve clinical outcomes in patients with coronary heart
disease (CHD). Ischemic conditioning—the practice of applying brief episodes of nonlethal …

Context Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of
morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and …

Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. For
a large number of patients with CHD, coronary artery bypass graft (CABG) surgery remains …

There is continued interest in the concept of limiting myocardial infarct size with adjunctive
agents administered along with reperfusion injury; however, there remains considerable …